Diego Wyszynski MD MHS, PhD

Founder and CEO, Noverion Life Sciences

1801 Century Park EastLos Angeles, CA 90067

Dr. Wyszynski is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wyszynski's full profile Already have an account?

Summary

Physician-scientist and epidemiologist with 25+ years of global leadership in pharmacovigilance, drug safety, and regulatory strategy. Founder of Pregistry, a specialty CRO in pregnancy and life-course drug safety, acquired by CorEvitas (Thermo Fisher Scientific). Former Vice President of Pregnancy & Lactation Studies at Thermo Fisher, leading global regulatory-required research programs with major pharmaceutical partners.Earlier senior safety leadership roles at Amgen and Boehringer Ingelheim with direct engagement across FDA, EMA, and MHRA.Currently Founder & CEO of Noverion Life Sciences, building a next-generation expert network to support high-stakes regulatory, clinical, and strategic decision-making in life sciences.

Clinical Expertise

Pregnancy, Epidemiologic typing, Epidemiology, Consultative service to pharmaceutical companies, Pregnancy registries, Drug Safety and Pharmacovigilance

Education & Training

University of Buenos AiresClass of 1991
Johns Hopkins School of Hygiene and Public HealthMHS, Epidemiology
Johns Hopkins School of Hygiene and Public HealthPhD, Epidemiology

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Awards, Honors, & Recognition

TEDMED Research Scholar TEDMED, 2017

Clinical Trials

COVID-19 Vaccines International Pregnancy Exposure Registry Start of enrollment: 2021 Jun 01
COMPLETED
COVID-19 International Drug Pregnancy Registry Start of enrollment: 2021 Dec 01
RECRUITING
Pregistry International Pregnancy Exposure Registry (PIPER) Start of enrollment: 2022 Oct 01
TERMINATED

Publications & Presentations

PubMed

5 citations
Association between SARS-CoV-2 infection during pregnancy and postpartum depressive and anxiety symptoms: finding from the International Registry of Coronavirus Exposu...
Sonia Kim, Sonia Hernández-Díaz, Yanmin Zhu, Diego Wyszynski, Krista F Huybrechts
Archives of Women's Mental Health. 2022-12-01
25 citations
Pregnancy and Birth Outcomes among Women with Idiopathic Thrombocytopenic Purpura
Diego F. Wyszynski, Wendy J. Carman, Alan B. Cantor, John M. Graham, Liza Kunz
Journal of Pregnancy. 2016-03-22
11 citations
Frequency and type of medications and vaccines used during pregnancy
Diego F Wyszynski, Kristine E Shields
Obstetric Medicine. 2016-03-01

Press Mentions

Dr. Cheryl Renz Joins Pregistry as Chief Medical OfficerMay 18th, 2022
Announcing the TEDMED 2017 Research ScholarsMarch 1st, 2017
Study Finds Anticonvulsant Drug Poses Greater Birth-Defect Risk Than SuspectedMarch 22nd, 2005